(Q33174985)

23 July 2017

title

Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects (English)

1 reference

23 July 2017

0 references

A Natale

1

1 reference

23 July 2017

K H Newby

2

1 reference

23 July 2017

A Dhala

3

1 reference

23 July 2017

M Akhtar

4

1 reference

23 July 2017

J Sra

5

1 reference

23 July 2017

language of work or name

1 reference

1 December 1996

1 reference

Journal of Cardiovascular Electrophysiology

23 July 2017

published in

1 reference

23 July 2017

volume

7

1 reference

23 July 2017

issue

12

1 reference

23 July 2017

page(s)

1154-1158

1 reference

Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Efficacy of Different Treatment Strategies for Neurocardiogenic Syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

The value of tilt table testing with isoproterenol in determining therapy in adults with syncope and presyncope of unexplained origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Relevance of asystole during head-up tilt testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Low dose disopyramide often fails to prevent neurogenic syncope during head-up tilt testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Reproducibility of head upright tilt table test results in patients with syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1996.TB00494.X

10.1111/J.1540-8167.1996.TB00494.X

21 January 2018

Identifiers

DOI

1 reference

23 July 2017

1 reference